1. Caspase-dependent signalling is important during heart morphogenesis and is later silenced in post-mitotic cardiomyocytes Cell death implying apoptotic-like DNA damage occurs during embryonic heart development. [13] [14] [15] Experiments using caspase inhibitors suggest that caspase-dependent cell death occurs in the cardiac regions submitted to important morphological changes, such as the ventriculoarterial connections, the atrioventricular cushions, and the conduction tissue. [16] [17] [18] Therefore, caspase activation is likely assuring the proper formation of the cardiac cavities and the correct docking of the arteries to the ventricles during development. Later, the caspase-dependent death machinery is repressed during cardiomyocyte terminal differentiation, 7, 12 as it has been described in retinal neurons. 19 
Mitochondrial damage implicated in post-mitotic cardiomyocyte death is not associated with caspase activation
Many reports have demonstrated that mitochondrial damage precedes post-mitotic cardiomyocyte cell death and have suggested the involvement of caspases 20 yet the engagement of these proteases downstream of mitochondrial damage is still debated [e.g. 4 vs. 21]. The Bcl-2 family controls mitochondrial events leading to caspase activation by regulating outer mitochondrial membrane permeabilization. However, mitochondrial damage also hinders aerobic metabolism and alters cellular Ca 2þ homeostasis. Thus, Bcl-2 and Bcl-XL-dependent cardioprotection could be achieved by maintaining mitochondrial physiology through preservation of mitochondrial membrane integrity. [22] [23] [24] [25] Further, supporting a role of mitochondrial damage unrelated to caspases yet involving Bcl-2-related proteins, Bnip3 induces caspase-independent mitochondrial permeabilization during cardiac ischaemia. 5 In this setting, myocyte DNA degradation is independent of caspases. 5, 7 In addition, high expression of Bcl-2 is suggested to limit autophagy in the heart. 26 Because of its relevance in cardiomyocyte homeostasis, 3, [27] [28] [29] autophagy is a process controlled by the Bcl-2 family that could affect cardiomyocyte viability.
Another event involved in mitochondrial damage is the destabilization of the inner mitochondrial membrane integrity (mitochondrial permeability transition, MPT). MPT dissipates the electrochemical gradient, affecting aerobic energy production, and triggering the release of mitochondrial proteins to the cytosol. 30 In cardiomyocytes, MPT is implied in cell death in a caspase-independent and Bcl-2-independent manner during ischaemia and reperfusion. 31 In addition, caspase-independent calpain activation ensuing from mitochondrial damage could also impair Na þ / K þ exchanger function, and hence Ca 2þ homeostasis, exacerbating cardiac cell death during reperfusion. 4, 32 Moreover, an increase in the cytosolic Ca 2þ pool could aggravate mitochondrial damage by increasing the cyclophilin-D-dependent MPT. 31 Finally, the antiapoptotic protein ARC (Apoptotic Repressor with CARD domain) 33, 34 that has been shown to safeguard the heart 34 and to block caspase activation in cell lines 35, 36 can also protect from caspase-independent death, 37, 38 suggesting that ARCdependent protection could be caspase-independent in post-mitotic cardiomyocytes.
The above evidences suggest that mitochondrial damage is an important event leading to cardiomyocyte death without downstream activation of caspases. Our results show that the disruption between cytochrome c release and caspase activity is due to the silencing of key pro-apoptotic genes including Apaf-1 and executioner caspases during cardiac development [6,7, see Figure 1 ]. This could be an evolutionary selection to prevent death of long-lived cardiomyocytes after release of cytochrome c in order to sustain viability in case of mitochondrial rupture.
3. Death receptor-dependent apoptosis is involved in non-myocyte cell death in experimental models of heart disease Fas-dependent signalling has been implicated in cardiomyocyte death during graft rejection and ischaemia/reoxygenation, as suggested by experiments comparing cardiomyocyte death in wild type mice and mice carrying loss-of-function mutations of either Fas or Fas ligand (FasL) genes (lpr and gld mice, respectively). [39] [40] [41] However, it has been demonstrated that cardiac graft salvage in lpr and gld mice is due to a general impairment of the host immune response, which normally would attack the graft, and not to a specific role of cardiac Fas signalling. 42 During ischaemia/reoxygenation-induced cardiomyocyte death, Fas and FasL have been shown recently to promote granulation tissue death but not cardiomyocyte loss. 43, 44 These results agree with the finding that the main role of caspase inhibitors given during experimental myocardial infarction is to protect non-myocardial cells. 11 Tumor necrosis factor-a (TNF-a) was reported to induce DNA damage in cultured adult cardiomyocytes, although the involvement of caspases was not checked. 45 However, recent reports using biochemical and genetic approaches have discarded a direct role of this cytokine in cardiomyocyte death. 46 -51 TNF-a genetic deficiency reduced cardiac inflammation and fibrosis, suggesting a role of TNF-a in granulation tissue signalling. 51 Interestingly, TNF-a also induces caspase activation in Figure 1 Literature-based hypothesis on the role of the caspase-dependent signalling cascade and the Bcl-2 protein family in the biology of the cardiomyocyte. In the cardiac embryonic cell (upper left panel), all the components of the caspase-dependent signalling pathway as well as the Bcl-2 family of proteins are expressed. The death receptor pathway is involved in myocardial differentiation by unknown mechanisms. Expression of Bcl-2 could account for the low autophagic activity. In the forming heart, some cells die by caspase-dependent mechanisms, although the relative contribution of the different pathways remains to be resolved (lower left panel). At the end of the terminal differentiation process (upper right panel), cardiomyocytes have lost the expression of the caspasedependent signalling cascade. Reduction in the expression of Bcl-2 allows an increase in basal autophagy, which helps in maintaining the homeostasis of these long-lived cells. Some components of the death receptor pathway could be involved in the hypertrophic response of adult cardiomyocytes, in addition to the well-known role of calcineurin A (CnA). Maladaptive hypertrophy, exacerbated autophagy and other harmful events lead to caspase-independent mitochondrial permeability transition (MPT), cytochrome c release and calcium signalling alterations, leading to cell dysfunction and death. In this diagram, other relevant pathways involved in cardioprotection, as well as the contribution of the sarcoplasmic reticulum (SPR), have been omitted for clarity. a-Bax, activated Bax; C3/7, caspases 3 and 7; C8, caspase-8; C9, caspase-9; CypD, cyclophilin-D; Cyt C, cytochrome c; DISC, death-inducing signalling complex; TRADD, TNF receptor-associated death domain. vascular endothelial cells, 52 which dye by apoptosis during congestive heart failure. 53 Therefore, the extrinsic pathway likely induces granulation tissue and endothelial cell death but not cardiomyocyte death during heart disease.
Death receptors play a relevant role in cardiomyocyte differentiation and growth
Against expectation, null mutation of some components of the death receptor pathway, such as Fas-associated death domain (FADD), caspase-8 and cFLIP, a caspase-8-like protein that lacks the protease motif, induce ventricular cell hypoplasia and non compaction of the ventricular wall in the embryo. [54] [55] [56] Interestingly, the role of these proteins in heart development seems to be independent of cell death because deficiency in the pro-apoptotic factors FADD and caspase-8, as well as lack of anti-apoptotic cFLIP, result in the same cardiac phenotype. On the contrary, experimental overexpression of Fas or FasL induces hypertrophy in cardiomyocytes. [57] [58] [59] Cardiac hypertrophy ensues also from TNF-a stimulation in vitro 46, 47 and in vivo.
48-49
In addition, mice lacking TNF receptors 1 and 2 have larger infarct areas than wild-type animals, 50 and TNF-a genetic deficiency decreases the hypertrophic growth of the myocardium after aortic banding. 51 These data suggest that cardiac death receptor activation triggers hypertrophy. Therefore, genetic and biochemical evidences suggest that the extrinsic pathway regulates cardiomyocyte differentiation and cardiac response to stress through cell deathindependent mechanisms that remain to be explored.
Concluding remarks
In our opinion, there is solid evidence suggesting that although caspase-dependent cell death is involved in heart morphogenesis, post-mitotic cardiomyocyte death is a caspase-independent event. This shift could come after the repression of pro-apoptotic genes in cardiomyocytes during differentiation (see Figure 1) . Caspase activation would affect indirectly post-mitotic myocyte cell survival and heart performance because it induces death of endothelial cells and granulation tissue. On the contrary, postmitotic cardiomyocyte death would ensue from mitochondrial damage, which hampers aerobic respiration and alters calcium homeostasis in the absence of caspases. In addition, death receptors and the Bcl-2 family regulate events that are essential for cardiac function, such as cell differentiation and mitochondrial integrity, and modulate the response to stress by inducing hypertrophy and controlling autophagy. The full comprehension of these events will have great therapeutic potential.
